- Home
- RLYB vs CNTY Comparison
RLYB vs CNTY Comparison
Compare RLYB & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLYB | CNTY |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.9M | 45.1M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RLYB | CNTY |
|---|---|---|
| Price | $13.89 | $1.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 60.9K | 36.6K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.31 |
| EPS | ★ N/A | N/A |
| Revenue | $858,000.00 | ★ $430,529,000.00 |
| Revenue This Year | N/A | $7.17 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 43.00 | 10.82 |
| 52 Week Low | $0.27 | $1.23 |
| 52 Week High | $11.49 | $2.85 |
Technical Indicators
Market Signals| Indicator | RLYB | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 89.64 | 39.62 |
| Support Level | $0.54 | $1.24 |
| Resistance Level | N/A | $1.47 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | 0.36 | -0.01 |
| Stochastic Oscillator | 88.65 | 0.00 |
Price Performance
Historical ComparisonAbout RLYB Rallybio Corporation
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.